Table 3.
Multivariate analyses of prognostic factors in HCC patients.
| Variables | Overall survival | Disease-free survival | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p-value | HR | 95% CI | p-value | |
| Gender | 0.783 | 0.456–1.783 | 0.342 | 0.974 | 0.545–2.013 | 0.251 |
| Age (years) | 0.978 | 0.554–2.132 | 0.432 | 1.241 | 0.678–2.342 | 0.268 |
| Tumor size | 1.453 | 0.832–2.342 | 0.134 | 1.554 | 0.942–2.456 | 0.117 |
| Tumor differentiation | 3.113 | 1.342–4.443 | 0.014 | 3.241 | 1.432–4.765 | 0.008 |
| Lymph node metastasis | 3.344 | 1.452–6.773 | 0.001 | 3.563 | 1.677–7.347 | 0.001 |
| Clinical stage | 2.896 | 1.327–5.138 | 0.012 | 3.183 | 1.442–5.348 | 0.008 |
| PITPNA–AS1 expression | 3.241 | 1.376–5.467 | 0.005 | 3.413 | 1.457–5.774 | 0.002 |